Kristen Laguerre, M.B.A.

Kristen Laguerre is an Executive Partner at MPM BioImpact. With over 25 years of financial leadership and management experience in the venture capital industry, her primary responsibility is to manage the firm’s Investment Committees, including overseeing investment processes and decisions and portfolio construction. Kristen joined MPM BioImpact in 2017 and previously served as the firm’s Chief Operating Officer and Chief Financial Officer. During her tenure, she also served as interim CFO at portfolio company ReNAgade Therapeutics (acquired by OrnaTherapeutics) and initial CFO at portfolio company Cullinan Therapeutics (NASDAQ: CGEM).

Prior to joining MPM BioImpact, Kristen served as Partner and CFO at Atlas Venture, Partner and CFO at Flare Capital Partners and previously as Vice President – Finance at Softbank Capital, where she was responsible for finance, human resources and operations associated with both Softbank’s venture funds and its global activities outside of East Asia. Earlier in her career, Kristen spent seven years in public accounting.

Kristen earned her M.B.A. in Finance and Accounting from Boston University and her B.A. in Economics from Wesleyan University.